Stockreport

What Catalysts Are Shaping the Changing Narrative for Ironwood Pharmaceuticals? [Yahoo! Finance]

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com
PDF Ironwood Pharmaceuticals has seen its price target revised upward, with the fair value estimate rising from $1.85 to $2.50 per share. This adjustment follows recent Medi [Read more]